Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer

Detalles Bibliográficos
Autores principales: Webster, Emily M., Zeybek, Burak, Tymon-Rosario, Joan, Santin, Alessandro D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640901/
https://www.ncbi.nlm.nih.gov/pubmed/33195736
http://dx.doi.org/10.18632/oncoscience.514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640901/
https://www.ncbi.nlm.nih.gov/pubmed/33195736
http://dx.doi.org/10.18632/oncoscience.514

Ejemplares similares